Budesonide

Active ingredient description

Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Budesonide
A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07E Intestinal antiinflammatory agents → A07EA Corticosteroids acting locally
Discover more medicines within A07EA06
Budesonide
D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC09
Budesonide
R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AD Corticosteroids
Discover more medicines within R01AD05
Budesonide
R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids
Discover more medicines within R03BA02

Medicines

Budesonide is the active ingredient of these drugs:

Drug
Countries

France

Tunisia

Italy United Kingdom

Germany

Cyprus

United Kingdom

Poland

Tunisia

Hong Kong

Cyprus Hong Kong

Italy

Italy

Australia

Germany

Brazil

South Africa

Poland United Kingdom

Hong Kong Spain Tunisia

Hong Kong

New Zealand

Australia Cyprus Estonia Finland Hong Kong

Poland

Ecuador

Ecuador

Italy

Lithuania

Austria Estonia Germany Lithuania Poland

Italy

Poland

Austria

Brazil

New Zealand

Brazil

Austria Canada Cyprus Ecuador Estonia

Tunisia

Hong Kong

Italy

South Africa Spain

Austria Brazil Canada Estonia Finland

United States

Hong Kong Singapore

Cyprus Singapore

Estonia Lithuania Singapore

Brazil

Brazil

Ecuador

South Africa

South Africa

Spain

Austria Canada Estonia Finland Ireland

Austria Brazil Cyprus Ecuador Estonia

France

France

Ecuador

Poland

Ecuador

Brazil

Spain

Finland France Germany

United States

South Africa

Italy

Australia Austria Brazil Canada Cyprus

Canada Estonia France Germany Hong Kong

Hong Kong

Spain

Poland

New Zealand

Poland

United States

Budesonide is also found within below combination drugs:

AIRBUFO , ALENIA , BIRESP SPIROMAX , BREZTRI , BUFAR EASYHALER , BUFOLER , BUFOMIX EASYHALER , BUFORI EASYHALER , BUSALAIR , BUSTEROL , COMBIFOR , DUASTMIN , DUORESP , ENTOCORT ENEMA , FOBUMIX , FORASEQ , GIBITER , NEUMOCORT PLUS , NOTOS COMBI , PULMELIA , PULMOTON , RILAST , RILTRAVA AEROSPHERE , SYMBICORD , SYMBICORT , TRIXEO AEROSPHERE , VANNAIR , VYLAER SPIROMAX

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

Q3OKS62Q6X - BUDESONIDE

CAS registry number

51333-22-3 - budesonide

SNOMED-CT

395726003 - Budesonide (substance)